Login
Australian medtech makes IPO
Gilbert & Tobin has advised an Aussie medtech company on its successful IPO and ASX listing.
Emma Musgrave
Firm: Gilbert + Tobin (CleanSpace)
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: Cleanspace has been advised on its IPO and offical listing on the Australian Securities Exchange (ASX).
Value: $550 million
Area: Corporate
Key players: The Gilbert + Tobin team was led by corporate advisory partner Tim Gordon with assistance from lawyers Lucy Hall, Matthew Wheatley and Emily Fanning.
Deal significance: According to a statement from Gilbert + Tobin, CleanSpace was founded in Sydney in 2009 by a team of biomedical engineers and now manufactures innovative respiratory protection products for the global healthcare and industrial sectors.
“It was a pleasure to work with CEO Dr Alexandra Birrell and the team at CleanSpace on their successful listing,” said Mr Gordon.
“It’s fantastic to help bring an Australian manufacturing and technology export success story to the ASX. Given the incredible hardships caused by the COVID 19 pandemic, we’re particularly proud to assist a company that provides best practice respiratory protection for healthcare and industrial workers. We expect to see great things in the future as CleanSpace continues its success.”
